ArticleApplied biochemistry and biotechnology2025
Pathway Reinforcement and Chassis Optimization of Escherichia coli BL21 for Enhancing Lacto‑N‑tetraose Production.
Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Lacto‑N‑tetraose (LNT) is an important neutral non-fucosylated form of human milk oligosaccharides, widely recognized for its protective effects on infant health and enhancement of immune functions. In this study, to reinforce the fermentative synthesis of LNT, lactose utilization was enhanced for LNT production through overexpressing lacY (encoding the lactose permease gene) in Escherichia coli BL21, which can achieve the LNT titer and productivity of 1.55 g/L and 0.02 g/L/h, respectively. Moreover, the chassis was optimized through deleting byproduct genes: wecB (encoding UDP-N-acetyl glucosamine-2-epimerase), lacZ (encoding β-galactosidase), and the nagB gene (encoding glucosamine-6-phosphate deaminase), so we can obtain a 2.8 g/L LNT titer and 0.039 g/L/h productivity. Furthermore, we designed the UTP regeneration for precursor production through overexpressing the ndk gene (encoding nucleoside diphosphate kinase) and increased the LNT titer by 3.02 g/L. Finally, the LNT titer and productivity were improved to 3.22 g/L and 0.05 g/L/h by integrating the LgtA-WbgO expression cassette in the genome. This study establishes a stepwise optimization strategy in Escherichia coli BL21 for LNT biosynthesis, providing a foundation for industrial-scale production.
Indexed as
Identifiers
41065979What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.